Prevalence and clinical outcomes of respiratory syncytial virus, COVID-19, and influenza among older hospitalized adults: the EVERY prospective cohort study
RSV should be recognized as a risk factor for mortality among older adults emergently hospitalized for acute respiratory symptoms.
Authors
- Mio Sakuma (ORCID: https://orcid.org/0000-0001-6574-1166)
- Haruki Imura (ORCID: https://orcid.org/0000-0001-8613-2431)
- Kenya Hamazaki (ORCID: https://orcid.org/0000-0002-3124-6607)
- Toru Morikawa
- Mari Nezu
- Tsukasa Nakamura
Institutions
- Morinomiya University of Medical Sciences (JP)
- Kobe Medical Center (JP)
- Rakuwakai Otowa Hospital (JP)
- Nara City Hospital (JP)
- Nara Medical University Hospital (JP)
- Shimane Prefectural Central Hospital (JP)
- Kobe City Medical Center West Hospital (JP)
- Kobe City Medical Center General Hospital (JP)
- Hyogo University (JP)
Publication Details
- Journal
- Clinical Microbiology and Infection
- Published
- 2026-01-01
- DOI
- https://doi.org/10.1016/j.cmi.2026.01.002
- Primary Topic
- Respiratory viral infections research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- GlaxoSmithKline